Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield. 1980

R T Wensley, and T J Snape

The effect on cryoprecipitate factor VIII recovery of three imortant variables has been investigated. The design of the study was such as to eliminate, for the purpose of internal comparisons, spurious effects such as those due to the variation in factor VIII levels in donor plasma. The choice of anticoagulant was shown to be of particular significance, plasma collected into CPD anticoagulant giving higher cryoprecipitate factor VIII yield thoughout the study. The effect on cryoprecipitate factor VIII recovery of delay before separation and freezing of the plasma was more complex. Very fresh plasma (separated and frozen within 2 h of collection) gave the highest recovery of factor VIII, but no difference was detected between cryoprecipitate factor VIII recovery of plasma separated and frozen at 4 h and at 18 h after blood collection. Controlled rapid thawing of the plasma was also shown to be advantageous, at least for the preparation of cryoprecipitates from plasma anticoagulated with CPD anticoagulant.

UI MeSH Term Description Entries
D011232 Chemical Precipitation The formation of a solid in a solution as a result of a chemical reaction or the aggregation of soluble substances into complexes large enough to fall out of solution. Precipitation, Chemical
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005615 Freezing Liquids transforming into solids by the removal of heat. Melting
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

R T Wensley, and T J Snape
January 1968, Thrombosis et diathesis haemorrhagica. Supplementum,
R T Wensley, and T J Snape
January 1976, Transfusion,
R T Wensley, and T J Snape
January 1970, Bibliotheca haematologica,
R T Wensley, and T J Snape
January 1984, Scandinavian journal of haematology. Supplementum,
R T Wensley, and T J Snape
July 1971, Vox sanguinis,
R T Wensley, and T J Snape
May 1977, British journal of haematology,
R T Wensley, and T J Snape
February 1970, Vox sanguinis,
R T Wensley, and T J Snape
April 1975, American journal of veterinary research,
R T Wensley, and T J Snape
July 1985, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!